ESG

The clinical trial leader renewed a key global certification, signaling a new era of quality and trust that could accelerate breakthroughs in Alzheimer's.

A new AI platform, SAVA, launched by EverythingALS, promises to connect ALS patients with clinical trials, tackling a major barrier in the search for a cure.

A novel immunotherapy that freezes and infuses tumors shows an 87% response rate in advanced prostate cancer, aiming to turn local treatment into a systemic attack.

With a key promotion, SES is betting on a future beyond solar, aiming to integrate HVAC, roofing, and new tech for Mid-Atlantic homeowners.

As AI accelerates drug approvals, a new bottleneck emerges. Firms like Totaligent are betting on the infrastructure needed to get therapies to patients.

Swedish firm Navinci launches its Omni kit, targeting the spatial interactomics market with a new tool to visualize protein networks directly in tissue.

After dominating online, Australian sun-safe apparel brand Solbari is launching in U.S. stores, betting on a booming market and a veteran sales chief.

Amid soaring inflation and trade chaos, the OPEC Fund launches E-STAR, a major initiative to shield vulnerable nations from escalating global crises.

For the third straight year, Baron Capital earns Cigna's top wellness award, revealing how employee vitality is becoming a key asset in finance.

With directors from The Lion King and Twilight on the jury, a top AI film festival signals a new cinematic era. What does this mean for creativity?

Sagicor Life Insurance appoints former National Life Group CFO Eric Sandberg as President, signaling a major push into the competitive U.S. annuity market.

TRexBio has dosed the first patient in a new trial for its novel drug, TRB-061, which aims to rebalance the immune system to treat atopic dermatitis.

As RNA therapies boom, a new enzymatic platform promises to solve critical manufacturing bottlenecks, making next-gen drugs more scalable and sustainable.

Chinese robotics firm KaiTu Technology debuts its AI-powered forklifts and AMRs in Silicon Valley, signaling a new era of global competition in automation.

Investment firm Malar Group backs wellness startup Attaboy Labs, betting on clinical science over marketing hype in the booming supplement industry.

Microban’s new EcoFresh odor control gets the USDA Certified Biobased label, signaling a major shift toward sustainable, high-performance textiles.

Taiwanese foundry UMC posts a 108% profit surge, driven by strong 22nm chip demand, a key Intel partnership, and a positive outlook despite global risks.

DJI's new report reveals agricultural drones cut 51Mt in carbon emissions and saved 410Mt of water, marking a major shift in global food production.

The hardware maker's strategic shift to high-value parts for AI and EVs results in a stunning 177% profit surge, signaling a new era of global growth.

Berlin-based Tacalyx is advancing its lead drug, TCX-201, to the clinic, targeting a novel class of antigens once thought impossible to drug.